Genetics Of Autoimmunity In Type I Diabetes
Medical College of Wisconsin · with Benaroya Research Institute, Indiana University · NCT03648918
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 2+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 4000
- US sites recruiting
- 1
- Study start
- August 2001
- Record last updated
- March 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to gain more information about the step-by-step process that causes someone to develop type 1 diabetes. Scientists think that a person's own immune system, directed by genetic and environmental factors play a major role in its development. Participation involves a blood draw, a brief medical history questionnaire and measurements of height and weight. Some participants will be asked to return for annual follow-up visits for 10 years.
Being studied: Blood Collection
Conditions: Type1diabetes; Diabetes Mellitus, Type 1; Type1 Diabetes Mellitus; Diabetes Mellitus
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria (Families):
- Families where at least one first-degree family member has type 1 diabetes
- The diabetic proband in the family was diagnosed before the age of 39
- Family members must be at least 2 years old to participate
Exclusion Criteria (Families):
- Families with no history of type 1 diabetes
- Families with a history of diabetes that is not type 1 (LADA, MODY, type 2 etc.)
Inclusion Criteria (Controls):
- No family history of type 1 diabetes or other autoimmune conditions
- Age 2 or older
Exclusion Criteria (Controls):
- Personal or family history of autoimmune disease
Recruiting US locations
Medical College of Wisconsin
Milwaukee, WI 53226
Site contact: Martin Hessner, PhD · 414-955-4903 · t1dinfo@mcw.edu
Study contacts (from the official record)
- Martin Hessner, PhD · 414-955-4903 · t1dinfo@mcw.edu
Similar studies in Wisconsin
All diabetes studies in Wisconsin →- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- La Crosse, WI + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Medical College of Wisconsin
- Location
- Milwaukee, WI
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- Milwaukee, WI + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Madison, WI + 9 other US sites
- Eligibility basics
- Ages 18–65